* Celsion Corp Says Has Completed Enrollment Of Second
Cohort Of Ovation Study And Expects To Report Clinical Data From
That Cohort Mid Year
The post BRIEF-Celsion expects to report translational data from first two cohorts of ovation study in Q3 appeared first on NASDAQ.